The report will be delivered in 2-3 business days.

Oral Biologics & Biosimilar Drugs Global Market Report 2021: COVID 19 Growth And Change to 2030

Starting Price : $5000 | Pages : 175 | Published : January 2021 | SKU CODE : | Format :


The oral biologics and biosimilar market consist of sales of oral biologics and biosimilar products and related services used to treat chronic diseases such as diabetes, arthritis, cancer. Biologics are drugs made from living cells using highly complex technology while biosimilars are created to function similarly to biologics but are not identical to biologics. Biosimilars offer active properties as any licensed biologic drug. The oral biologics and biosimilar market comprise of biologics and biosimilar drugs taken orally for the targeted treatment of Alzheimer's, multiple sclerosis, HIV/AIDS and other serious conditions.

The global oral biologics & biosimilar drugs market is expected to grow from $3.53 billion in 2020 to $4.1 billion in 2021 at a compound annual growth rate (CAGR) of 16.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $8.69 billion in 2025 at a CAGR of 21%.

North America was the largest region in the global oral biologics & biosimilar drugs market, accounting for 46% of the market in 2019. Asia Pacific was the second largest region accounting for 24% of the global market. Eastern Europe was the smallest region in the global oral biologics & biosimilar drugs market.

The rising prevalence of chronic diseases such as arthritis, asthma, cancer is expected to be a major driver of the oral biologics and biosimilar market. Long working hours, limited physical activity, unhealthy eating and drinking habits contribute to the prevalence of chronic diseases and biologics are increasingly used to treat these chronic diseases. Biologics activate the immune system response against cancer cells thus helping the immune system to eliminate the cancer cells from the body. According to a United Nations article, by 2030 the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic disease is expected to reach about 60%. Therefore, the rise in the prevalence of chronic diseases is projected to propel the demand for biologics and biosimilars, thus driving the biologics and biosimilar market.

Stringent regulations imposed on approval of biosimilar is anticipated to hinder the growth of oral biologics and biosimilar market in the forecast period. The governments of different regions impose different rules regarding the production and use of biologics and biosimilars. Further, issues such as patent infringement or agreement issues restrict the manufacturers of biologics and biosimilars from commercializing the government-approved biosimilars. The US Food and Drug Administration requires a double regulatory approval for biosimilars, restricting the use of biosimilars as an interchangeable drug to biologics whereas, in Europe, the European Medicines Agency (EMA) approves biosimilars as interchangeable products for biologics. In February 2019, out of the total 17 approved biosimilars only 7 biosimilars including 4 originating biologics could enter the US commercial market. The robust government policies for approval of these drugs impact the manufacturers in oral biologics and biosimilar market.

The latest trend in the oral biologics and biosimilar market is the creation of new insulin biosimilars. The key players operating in the oral biologics and biosimilar market are investing in creating a biosimilar copy of insulin. This is also promoting competition among various biosimilar manufacturers. Following the trend, Mylan, a USA based pharmaceuticals company, in partnership with Biocon launched biosimilar insulin glargine named Semglee, in 2019 in Australia. Biocon is an Indian based biopharmaceutical company. In 2019, Oramed Pharmaceuticals, a Jerusalem based pharmaceutical company developed an oral insulin drug named ORMD-0801 to treat type 2 diabetes. Thus, companies in the oral biologics and biosimilar market are investing in the trend of developing biosimilar of insulin to gain profit.

The major players covered in the global oral biologics & biosimilar drugs market are Novartis, Rani Therapeutics, Eli Lilly and Co., AstraZeneca plc, Novo Nordisk A/S, Biocon Limited, Oramed Pharmaceuticals, BiosanaPharma, Entera Bio Ltd., Allergan plc, Emisphere Technologies, Enteris BioPharma, Chiasma, Allena Pharmaceuticals, Gelgen, Ganlee, 3sbio, Innovent, Retractable Technologies, Inc., Changchun High Tech, Dong Bao, CP Guojian, GlaxoSmithKline Plc., Concord Biotech, Aurobindo Pharma Ltd., H. Lundbeck A/S, Sanofi-Aventis, Roche.

The countries covered in the global oral biologics & biosimilar drugs market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia.

The regions covered in the global oral biologics & biosimilar drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global oral biologics & biosimilar drugs market is segmented -

1) By Therapy: Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors,

2) By Disease: Asthma, Crohn'S Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others

3) By Molecule Type: Vaccines, Proteins & Peptides, Monoclonal Antibodies, Others

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    1. Executive Summary

    2. Oral Biologics & Biosimilars Market Characteristics

    3. Oral Biologics & Biosimilars Market Trends And Strategies

    4. Impact Of COVID-19 On Oral Biologics & Biosimilars

    5. Oral Biologics & Biosimilars Market Size And Growth

    5.1. Global Oral Biologics & Biosimilars Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Oral Biologics & Biosimilars Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Oral Biologics & Biosimilars Market Segmentation

    6.1. Global Oral Biologics & Biosimilars Market, Segmentation  By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Lymphocyte Modulators

    Interleukin Inhibitors

    Tumor Necrosis Factor-Alpha Inhibitors

    6.2. Global Oral Biologics & Biosimilars Market, Segmentation  By Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Asthma

    Crohn'S Disease

    Carcinoma

    Arthritis

    Diabetes

    Multiple Myeloma

    Enterocolitis

    Multiple Sclerosis

    Sarcoma

    Psoriasis and Others

    6.3. Global Oral Biologics & Biosimilars Market, Segmentation  By Molecule Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Vaccines

    Proteins & Peptides

    Monoclonal Antibodies

    Others

    6.4. Global Oral Biologics & Biosimilars Market, Segmentation  By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    7. Oral Biologics & Biosimilars Market Regional And Country Analysis

    7.1. Global Oral Biologics & Biosimilars Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Oral Biologics & Biosimilars Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Oral Biologics & Biosimilars Market  

    8.1. Asia-Pacific Oral Biologics & Biosimilars Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Oral Biologics & Biosimilars Market  

    9.1. China Oral Biologics & Biosimilars Market Overview  

    9.2. China Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Oral Biologics & Biosimilars Market  

    10.1. India Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Oral Biologics & Biosimilars Market  

    11.1. Japan Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Oral Biologics & Biosimilars Market  

    12.1. Australia Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Oral Biologics & Biosimilars Market  

    13.1. Indonesia Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Oral Biologics & Biosimilars Market  

    14.1. South Korea Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Oral Biologics & Biosimilars Market  

    15.1. Western Europe Oral Biologics & Biosimilars Market Overview

    15.2. Western Europe Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Oral Biologics & Biosimilars Market  

    16.1. UK Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Oral Biologics & Biosimilars Market  

    17.1. Germany Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Oral Biologics & Biosimilars Market  

    18.3. France Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Oral Biologics & Biosimilars Market  

    19.1. Eastern Europe Oral Biologics & Biosimilars Market Overview

    19.2. Eastern Europe Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Oral Biologics & Biosimilars Market  

    20.1. Russia Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Oral Biologics & Biosimilars Market  

    21.1. North America Oral Biologics & Biosimilars Market Overview

    21.2. North America Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Oral Biologics & Biosimilars Market  

    22.1. USA Oral Biologics & Biosimilars Market Overview

    22.2. USA Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Oral Biologics & Biosimilars Market  

    23.1. South America Oral Biologics & Biosimilars Market Overview

    23.2. South America Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Oral Biologics & Biosimilars Market  

    24.1. Brazil Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Oral Biologics & Biosimilars Market  

    25.1. Middle East Oral Biologics & Biosimilars Market Overview

    25.2. Middle East Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Oral Biologics & Biosimilars Market  

    26.1. Africa Oral Biologics & Biosimilars Market Overview

    26.2. Africa Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Oral Biologics & Biosimilars Market Competitive Landscape And Company Profiles

    27.1. Oral Biologics & Biosimilars Market Competitive Landscape

    27.2. Oral Biologics & Biosimilars Market Company Profiles

    27.2.1. Novartis

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Rani Therapeutics

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3.  Eli Lilly and Co.

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. AstraZeneca plc

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Novo Nordisk A/S

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Oral Biologics & Biosimilars Pipeline Analysis

    29. Key Mergers And Acquisitions In The Oral Biologics & Biosimilars Market

    30. Oral Biologics & Biosimilars Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Research Inquiries

    31.4. The Business Research Company

    31.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Oral Biologics & Biosimilars Market, Segmentation  By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Oral Biologics & Biosimilars Market, Segmentation  By Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Oral Biologics & Biosimilars Market, Segmentation  By Molecule Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Oral Biologics & Biosimilars Market, Segmentation  By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Oral Biologics & Biosimilars Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Global Oral Biologics & Biosimilars Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: China, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: India, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: Japan, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: Australia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: Indonesia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: South Korea, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: Western Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: UK, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Germany, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: France, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: Eastern Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: Russia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: North America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: USA, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: South America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: Brazil, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: Middle East, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: Africa, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: Novartis Financial Performance
  • Table 29: Rani Therapeutics Financial Performance
  • Table 30:  Eli Lilly and Co. Financial Performance
  • Table 31: AstraZeneca plc Financial Performance
  • Table 32: Novo Nordisk A/S Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Oral Biologics & Biosimilars Market, Segmentation  By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Oral Biologics & Biosimilars Market, Segmentation  By Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Oral Biologics & Biosimilars Market, Segmentation  By Molecule Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Oral Biologics & Biosimilars Market, Segmentation  By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Oral Biologics & Biosimilars Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Global Oral Biologics & Biosimilars Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: China, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: India, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: Japan, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: Australia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: Indonesia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: South Korea, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: Western Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: UK, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Germany, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: France, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: Eastern Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: Russia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: North America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: USA, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: South America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: Brazil, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: Middle East, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: Africa, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: Novartis Financial Performance
  • Figure 29: Rani Therapeutics Financial Performance
  • Figure 30:  Eli Lilly and Co. Financial Performance
  • Figure 31: AstraZeneca plc Financial Performance
  • Figure 32: Novo Nordisk A/S Financial Performance
Global Cancer Monoclonal Antibodies Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Clinical Nutrition Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cervical Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Central Nervous System Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Checkpoint Inhibitors Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell Culture Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell And Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Biosimilar Interleukins Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Immuno-Oncology Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Psoriatic Arthritis Treatment Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Biosimilar Growth Hormones Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Biosimilar Lymphocyte Modulator Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Neutropenia Biologic Drug Treatment Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Anti-Parkinson Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
View Report
Microbiome Global Market Report 2021: COVID 19 Growth And Change to 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)